Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-26 @ 10:57 AM
NCT ID:
NCT03866408
Eligibility Criteria:
Inclusion Criteria:
* Men and Women between the ages of 18 and 55.
* Women will be premenopausal
* Non obese adults BMI between 18-25
* Obese BMI 30-38
Exclusion Criteria, Pioglitazone package insert of contraindications for use:
* Initiation in patients with established New York Heart Associations (NYHA) class III or IV Heart failure.
* Use in patients with known hypersensitivity to pioglitazone or any other component of ACTOSE.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT03866408
Study Brief:
Protocol Section:
NCT03866408